Karyopharm myeloma drug yields mixed data in myelofibrosis trial

BioPharma Dive

Xpovio combined with Incyte s Jakafi helped on one key measure but missed on other goal in a disorder that, by one analyst s estimates, could triple the company s revenue.

Clinical DataHematologyRead full story